SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-23-000051
Filing Date
2023-05-04
Accepted
2023-05-04 16:06:13
Documents
46
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20230331.htm   iXBRL 10-Q 1163474
2 EX-31.1 lfvn_033123xex311.htm EX-31.1 9732
3 EX-31.2 lfvn_033123xex312.htm EX-31.2 9712
4 EX-32.1 lfvn_033123xex321.htm EX-32.1 5035
5 EX-32.2 lfvn_033123xex322.htm EX-32.2 5015
  Complete submission text file 0000849146-23-000051.txt   4717014

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20230331.xsd EX-101.SCH 24864
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20230331_cal.xml EX-101.CAL 56048
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20230331_def.xml EX-101.DEF 96907
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20230331_lab.xml EX-101.LAB 406832
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20230331_pre.xml EX-101.PRE 231613
40 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20230331_htm.xml XML 690873
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 23888635
SIC: 2834 Pharmaceutical Preparations